PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Laboratory Medicine, Keio University School of Medicine, Tokyo, Japan; Department of Infectious Diseases, Keio University School of Medicine, Tokyo, Japan. Electronic address: uwamino@keio.jp.\', \'Environmental Science for Sustainable Development, Graduate School of Agricultural and Life Science, University of Tokyo, Tokyo, Japan; Department of Infectious Diseases, Keio University School of Medicine, Tokyo, Japan.\', \'Center for Medical Genetics, Keio University School of Medicine, Tokyo, Japan.\', \'Health Center, Keio University, Tokyo, Japan.\', \'Department of Preventive Medicine and Public Health, Keio University School of Medicine, Tokyo, Japan.\', \'Department of Laboratory Medicine, Keio University School of Medicine, Tokyo, Japan.\', \'Department of Infectious Diseases, Keio University School of Medicine, Tokyo, Japan.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0264-410X(22)00191-810.1016/j.vaccine.2022.02.047
?:hasPublicationType
?:journal
  • Vaccine
is ?:pmid of
?:pmid
?:pmid
  • 35183387
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.863
?:rankingScore_hIndex
  • 159
?:title
  • The effect of the E484K mutation of SARS-CoV-2 on the neutralizing activity of antibodies from BNT162b2 vaccinated individuals.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all